Clinical characteristics and treatment patterns of new users of dapagliflozin for heart failure with reduced ejection fraction: an observational study programme across 12 countries (EVOLUTION HF)
Event: ESC Congress 2024
Topic: Pharmacotherapy
Session: Drug therapy for heart failure: what is new?
